---
figid: PMC5854933__br-08-03-0215-g00
figlink: /pmc/articles/PMC5854933/figure/f1-br-0-0-1045/
number: F1
caption: Schematic diagram depicting the proposed WNT pathway antagonists, inhibitors
  and modulators. The WNT receptor and its downstream targets are considered as promising
  therapeutic targets for the treatment of mucinous ovarian cancer. Arrows indicate
  modulators. LRP5/6, lipoprotein receptor-related protein 5/6; Fzd, Frizzled; sFzd7,
  soluble Fzd7 peptide; RNF43, ring finger protein 43; DKK, Dickkopf1; DVL, Dishevelled;
  TMEM88, transmembrane protein 88; HUWE1, HECT, UBA and WWE domain-containing 1;
  WWOX, WW domain-containing oxidoreductase; DACT1, dishevelled-binding antagonist
  of β-catenin; GSK3β, glycogen synthase kinase 3β; DIF, differentiation-inducing
  factor; CK1, casein kinase 1; APC, adenomatous polyposis coli; CDX2, caudal type
  homeobox 2; TCF, T-cell factor; TNIK, Traf2 and Nck-interacting protein kinase.
pmcid: PMC5854933
papertitle: Potential signaling pathways as therapeutic targets for overcoming chemoresistance
  in mucinous ovarian cancer.
reftext: Emiko Niiro, et al. Biomed Rep. 2018 Mar;8(3):215-223.
pmc_ranked_result_index: '61985'
pathway_score: 0.8451996
filename: br-08-03-0215-g00.jpg
figtitle: WNT pathway
year: '2018'
organisms:
- Homo sapiens
ndex: e46684bf-df21-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5854933__br-08-03-0215-g00.html
  '@type': Dataset
  description: Schematic diagram depicting the proposed WNT pathway antagonists, inhibitors
    and modulators. The WNT receptor and its downstream targets are considered as
    promising therapeutic targets for the treatment of mucinous ovarian cancer. Arrows
    indicate modulators. LRP5/6, lipoprotein receptor-related protein 5/6; Fzd, Frizzled;
    sFzd7, soluble Fzd7 peptide; RNF43, ring finger protein 43; DKK, Dickkopf1; DVL,
    Dishevelled; TMEM88, transmembrane protein 88; HUWE1, HECT, UBA and WWE domain-containing
    1; WWOX, WW domain-containing oxidoreductase; DACT1, dishevelled-binding antagonist
    of β-catenin; GSK3β, glycogen synthase kinase 3β; DIF, differentiation-inducing
    factor; CK1, casein kinase 1; APC, adenomatous polyposis coli; CDX2, caudal type
    homeobox 2; TCF, T-cell factor; TNIK, Traf2 and Nck-interacting protein kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DACT1
  - FZD8
  - MYC
  - HUWE1
  - LRP5
  - CSNK1A1
  - TMEM88
  - AXIN1
  - TNIK
  - FZD9
  - FZD4
  - FZD6
  - FZD7
  - FZD10
  - LRP6
  - GSK3B
  - AXIN2
  - CTNNB1
  - APC
  - FZD2
  - DKK1
  - FZD5
  - CDX2
  - TNF
  - WWOX
  - FZD3
  - FZD1
  - Salinomycin
  - Prodigiosin
  - Prodigiosin 3289-8625
  - NSC668036
  - Niclosamide
  - Polyphyllin
  - Mebendazole
  - NCB-0846
  - Pyrvinium
genes:
- word: DACT1
  symbol: DACT1
  source: hgnc_symbol
  hgnc_symbol: DACT1
  entrez: '51339'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: C-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: HUWE1
  symbol: HUWE1
  source: hgnc_symbol
  hgnc_symbol: HUWE1
  entrez: '10075'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: TMEM88
  symbol: TMEM88
  source: hgnc_symbol
  hgnc_symbol: TMEM88
  entrez: '92162'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: TNIK
  symbol: TNIK
  source: hgnc_symbol
  hgnc_symbol: TNIK
  entrez: '23043'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Fzd7
  symbol: FZD7
  source: hgnc_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: DKK1
  symbol: DKK1
  source: hgnc_symbol
  hgnc_symbol: DKK1
  entrez: '22943'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: CDX2
  symbol: CDX2
  source: hgnc_symbol
  hgnc_symbol: CDX2
  entrez: '1045'
- word: DIF
  symbol: DIF
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: wwox
  symbol: WWOX
  source: hgnc_symbol
  hgnc_symbol: WWOX
  entrez: '51741'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
chemicals:
- word: Salinomycin
  source: MESH
  identifier: C010327
- word: Prodigiosin
  source: MESH
  identifier: D011353
- word: Prodigiosin 3289-8625
  source: MESH
  identifier: C542873
- word: NSC668036
  source: MESH
  identifier: C534585
- word: Niclosamide
  source: MESH
  identifier: D009534
- word: Polyphyllin
  source: MESH
  identifier: C000597304
- word: Mebendazole
  source: MESH
  identifier: D008463
- word: NCB-0846
  source: ''
  identifier: ''
- word: Pyrvinium
  source: MESH
  identifier: C024631
diseases: []
figid_alias: PMC5854933__F1
redirect_from: /figures/PMC5854933__F1
figtype: Figure
---
